Table 3 The association between LAG3 expression and clinical variables
|  | mRNA (N = 86) |  | IHC (N = 37) |  |
|---|---|---|---|---|
Characteristics | 95% CI | P value | 95% CI | P value |
Age | -4.204–4.421 | 0.9602 | -13.52–-2.253 | 0.0074 |
Sex | ||||
 Male vs Female | -1.302–0.5980 | 0.4633 | -0.5928–0.2928 | 0.4962 |
Stage | ||||
 II vs. I | -1.557–0.8468 | 0.5476 | -0.8717–0.0308 | 0.0659 |
 III vs. I | -1.424–0.8595 | 0.6220 | -0.8338–-0.0753 | 0.0212 |
 IV vs. I | -1.254–2.016 | 0.6347 | -0.7821–0.2626 | 0.3075 |
Histology | ||||
 Epithelioid vs Biphasic + Sarcomatoid | -0.7542–0.9437 | 0.8248 | -0.5368–0.1214 | 0.2083 |
 Smoking history | ||||
 Never vs Ex + Current |  |  | -0.5036–0.2203 | 0.4325 |
Respiratory function test | ||||
 %VC ≥ 80 vs. %VC < 80 |  |  | -0.1849–0.5182 | 0.3407 |